Fred Hassan is the chairman of Bausch + Lomb. He was elected to this role in March 2010.

Mr. Hassan is the former chairman and chief executive officer of Schering-Plough Corporation. He serves currently on the boards of Avon and Time-Warner, and is a senior advisor with the private equity firm Warburg Pincus.

Hassan was chairman and chief executive officer of Schering-Plough Corporation from 2003 until its merger with Merck & Co. in November 2009. He previously served as chief executive officer and as chairman and chief executive officer of Pharmacia Corporation from 2001 to 2003 until its acquisition by Pfizer Inc. Mr. Hassan is also the former chief executive officer of Pharmacia and Upjohn Inc., which merged with the Monsanto Corporation to become Pharmacia Corporation in 2000.

He is a member of The Business Council, and is the past chairman of the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA).

In February 2013, he released "Reinvent: A Leader's Playbook for Serial Success," in which he explains how to transform a struggling business into a raging success by reinventing the culture, attitude, and behaviors of organizations and people.

He holds a bachelor's of science degree from the Imperial College of Science and Technology at the University of London and an M.B.A. degree from Harvard Business School.

Change Management, Management, Business Leadership, Healthcare Policy, Authors, Business, Big Think, Health, Nutrition, Science, Healthcare, Technology, Leadership, Economy Finance,